UTILISATION THERAPEUTIQUE, DIETETIQUE OU COSMETIQUE DE COMPOSES AYANT UNE ACTIVITE ANTI-APOPTOTIQUE SPECIFIQUE ORIENTEE VERS LA CASPASE-3 ET COMPOSITIONS RENFERMANT CES COMPOSES
This invention regards the use of zeaxanthin and/or rutin, as such or furthercombined with spermidine, as the activeprinciple in a pharmaceutical, dietary, or cosmetic composition, acting toinhibit caspase-3 and therefore to control apoptosisby preventing programmed cell death. The indication for this compositionaccording to the invention is primarily the treatment ofscalp disorders characterized by excessive cellular turnover includingchemotherapy-induced alopecia, alopecia areata,androgenetic alopecia and telogen effluvium.